Log In
BCIQ
Print this Print this
 

Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)

  Manage Alerts
Collapse Summary Pipeline Information
 Pipeline Summary for Products Targeting Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)

BCIQ
Print ChartPrint this
Phase III, 2 Phase II, 2 Phase I, 1 Preclinical, 1
Phase of DevelopmentPreclinicalPhase IPhase IIPhase III
Cancer

1

-

-

-

Hematology

-

1

2

2




 Products Targeting Hypoxia-inducible factor prolyl hydroxylase (HIF-PH) (EGLN)
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Summary
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

$350.0M

$390.0M

$250.0M


 Deals Details
Get a free BioCentury Trial today